501 related articles for article (PubMed ID: 23109883)
1. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters.
Lee DH; Gold R; Linker RA
Int J Mol Sci; 2012; 13(9):11783-11803. PubMed ID: 23109883
[TBL] [Abstract][Full Text] [Related]
2. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
Linker RA; Lee DH; Ryan S; van Dam AM; Conrad R; Bista P; Zeng W; Hronowsky X; Buko A; Chollate S; Ellrichmann G; Brück W; Dawson K; Goelz S; Wiese S; Scannevin RH; Lukashev M; Gold R
Brain; 2011 Mar; 134(Pt 3):678-92. PubMed ID: 21354971
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.
Wang Q; Chuikov S; Taitano S; Wu Q; Rastogi A; Tuck SJ; Corey JM; Lundy SK; Mao-Draayer Y
Int J Mol Sci; 2015 Jun; 16(6):13885-907. PubMed ID: 26090715
[TBL] [Abstract][Full Text] [Related]
4. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Ahuja M; Ammal Kaidery N; Yang L; Calingasan N; Smirnova N; Gaisin A; Gaisina IN; Gazaryan I; Hushpulian DM; Kaddour-Djebbar I; Bollag WB; Morgan JC; Ratan RR; Starkov AA; Beal MF; Thomas B
J Neurosci; 2016 Jun; 36(23):6332-51. PubMed ID: 27277809
[TBL] [Abstract][Full Text] [Related]
5. Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases.
Majkutewicz I
Eur J Pharmacol; 2022 Jul; 926():175025. PubMed ID: 35569547
[TBL] [Abstract][Full Text] [Related]
6. Role of dimethyl fumarate in oxidative stress of multiple sclerosis: A review.
Suneetha A; Raja Rajeswari K
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Apr; 1019():15-20. PubMed ID: 26899449
[TBL] [Abstract][Full Text] [Related]
7. [Fumaric acid and its esters in the treatment of multiple sclerosis: studies and effects].
Stangel M; Moharregh-Khiabani D; Linker RA; Gold R
Nervenarzt; 2008 Feb; 79(2):212-7. PubMed ID: 18210050
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of fumaric acid esters in the R6/2 and YAC128 models of Huntington's disease.
Ellrichmann G; Petrasch-Parwez E; Lee DH; Reick C; Arning L; Saft C; Gold R; Linker RA
PLoS One; 2011 Jan; 6(1):e16172. PubMed ID: 21297955
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
Schulze-Topphoff U; Varrin-Doyer M; Pekarek K; Spencer CM; Shetty A; Sagan SA; Cree BA; Sobel RA; Wipke BT; Steinman L; Scannevin RH; Zamvil SS
Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4777-82. PubMed ID: 27078105
[TBL] [Abstract][Full Text] [Related]
10. Fumarates promote cytoprotection of central nervous system cells against oxidative stress via the nuclear factor (erythroid-derived 2)-like 2 pathway.
Scannevin RH; Chollate S; Jung MY; Shackett M; Patel H; Bista P; Zeng W; Ryan S; Yamamoto M; Lukashev M; Rhodes KJ
J Pharmacol Exp Ther; 2012 Apr; 341(1):274-84. PubMed ID: 22267202
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Effects of Sinomenine on Experimental Autoimmune Encephalomyelitis via Anti-Inflammatory and Nrf2-Dependent Anti-Oxidative Stress Activity.
Fan H; Yang Y; Bai Q; Wang D; Shi X; Zhang L; Yang Y
Neuromolecular Med; 2023 Dec; 25(4):545-562. PubMed ID: 37735290
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of rutin against cuprizone-induced multiple sclerosis in mice.
Nicola MA; Attaai AH; Abdel-Raheem MH; Mohammed AF; Abu-Elhassan YF
Inflammopharmacology; 2024 Apr; 32(2):1295-1315. PubMed ID: 38512652
[TBL] [Abstract][Full Text] [Related]
13. Spotlight on fumarates.
Lee DH; Linker RA; Gold R
Int MS J; 2008 Mar; 15(1):12-8. PubMed ID: 18713564
[TBL] [Abstract][Full Text] [Related]
14. Fumaric acid esters promote neuronal survival upon ischemic stress through activation of the Nrf2 but not HIF-1 signaling pathway.
Lin-Holderer J; Li L; Gruneberg D; Marti HH; Kunze R
Neuropharmacology; 2016 Jun; 105():228-240. PubMed ID: 26801077
[TBL] [Abstract][Full Text] [Related]
15. The KEAP1-NRF2 System and Neurodegenerative Diseases.
Uruno A; Yamamoto M
Antioxid Redox Signal; 2023 May; 38(13-15):974-988. PubMed ID: 36930785
[No Abstract] [Full Text] [Related]
16. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
17. Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration.
Schilling S; Goelz S; Linker R; Luehder F; Gold R
Clin Exp Immunol; 2006 Jul; 145(1):101-7. PubMed ID: 16792679
[TBL] [Abstract][Full Text] [Related]
18. Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses.
Wipke BT; Hoepner R; Strassburger-Krogias K; Thomas AM; Gianni D; Szak S; Brennan MS; Pistor M; Gold R; Chan A; Scannevin RH
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33468560
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into the multiple binding modes of Dimethyl Fumarate (DMF) and its analogs to the Kelch domain of Keap1.
Unni S; Deshmukh P; Krishnappa G; Kommu P; Padmanabhan B
FEBS J; 2021 Mar; 288(5):1599-1613. PubMed ID: 32672401
[TBL] [Abstract][Full Text] [Related]
20. Effects of fumaric acid esters on blood-brain barrier tight junction proteins.
Bénardais K; Pul R; Singh V; Skripuletz T; Lee DH; Linker RA; Gudi V; Stangel M
Neurosci Lett; 2013 Oct; 555():165-70. PubMed ID: 24076006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
